JEIL PHARMACEUTICAL CO.,LTD
Global manufacturer of pharmaceutical APIs, antibiotics, and injection-based treatments.
271980 | KO
Overview
Corporate Details
- ISIN(s):
- KR7271980005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 사평대로 343 제일약품 사옥, 서초구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Founded in 1959, Jeil Pharmaceutical Co., Ltd. develops, manufactures, and distributes pharmaceutical products to promote human health. The company's core activities include the production of active pharmaceutical ingredients (APIs), intermediates, and finished medicines, with a notable focus on injection-based treatments. Operating from GMP-certified facilities, Jeil Pharmaceutical's portfolio includes various therapeutic agents, such as antibiotics. The company is expanding its reach from its domestic market to a global scale, supplying its products to other nations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-06-04 00:00 |
Governance Information
[기재정정]기업지배구조보고서공시
|
Korean | 959.3 KB | ||
| 2025-05-29 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 952.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.5 MB | ||
| 2025-03-25 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 25.9 KB | ||
| 2025-03-25 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 12.7 KB | ||
| 2025-03-25 00:00 |
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
|
Korean | 5.5 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.8 KB | ||
| 2025-03-17 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 463.9 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 946.6 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 15.5 KB | ||
| 2025-02-24 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 13.8 KB | ||
| 2024-12-05 00:00 |
Share Issue/Capital Change
[기재정정]유상증자결정(종속회사의주요경영사항)
|
Korean | 25.8 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.3 MB | ||
| 2024-11-08 00:00 |
Share Issue/Capital Change
[기재정정]유상증자결정(종속회사의주요경영사항)
|
Korean | 23.5 KB |
Automate Your Workflow. Get a real-time feed of all JEIL PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for JEIL PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JEIL PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
